(60 Tests)

Measurement of high sensitivity CRP may add to the predictive value of other markers used to assess the risk of cardiovascular and peripheral vascular diseases.

PATHFAST determines the quantity of hsCRP from both whole blood and plasma samples, providing results within minutes, and facilitating critical care decisions for patients with acute myocardial infarction, deep vein thrombosis, pulmonary embolism and congestive heart failure.

FDA Cleared for Moderate Complexity Labs - Not CLIAwaived.


Assay range:  0.05 - 30 mg/L

Total imprecision at 4.63 mg/L, near the 97.5% reference interval of 4.16 mg/L:  8.4%

Correlation between lithium heparin plasma and whole blood:  R = 0.996

Correlation between lithium heparin plasma and EDTA-2K plasma:  R = 0.993

Correlation between lithium heparin plasma and EDTA-2K whole blood:  R = 0.995


*Data above listed on the product indication for use (IFU)

© 2020 Cliawaived, Inc. All Rights Reserved. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.